1. Home
  2. RARE vs NSA Comparison

RARE vs NSA Comparison

Compare RARE & NSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RARE
  • NSA
  • Stock Information
  • Founded
  • RARE 2010
  • NSA 2013
  • Country
  • RARE United States
  • NSA United States
  • Employees
  • RARE N/A
  • NSA N/A
  • Industry
  • RARE Biotechnology: Pharmaceutical Preparations
  • NSA Real Estate Investment Trusts
  • Sector
  • RARE Health Care
  • NSA Real Estate
  • Exchange
  • RARE Nasdaq
  • NSA Nasdaq
  • Market Cap
  • RARE 3.5B
  • NSA 2.5B
  • IPO Year
  • RARE 2014
  • NSA 2015
  • Fundamental
  • Price
  • RARE $36.68
  • NSA $32.06
  • Analyst Decision
  • RARE Strong Buy
  • NSA Hold
  • Analyst Count
  • RARE 15
  • NSA 10
  • Target Price
  • RARE $90.53
  • NSA $40.83
  • AVG Volume (30 Days)
  • RARE 1.1M
  • NSA 1.2M
  • Earning Date
  • RARE 07-31-2025
  • NSA 08-04-2025
  • Dividend Yield
  • RARE N/A
  • NSA 7.12%
  • EPS Growth
  • RARE N/A
  • NSA N/A
  • EPS
  • RARE N/A
  • NSA 0.12
  • Revenue
  • RARE $590,689,000.00
  • NSA $742,357,000.00
  • Revenue This Year
  • RARE $18.94
  • NSA N/A
  • Revenue Next Year
  • RARE $28.93
  • NSA $3.62
  • P/E Ratio
  • RARE N/A
  • NSA $264.26
  • Revenue Growth
  • RARE 33.46
  • NSA N/A
  • 52 Week Low
  • RARE $29.59
  • NSA $30.88
  • 52 Week High
  • RARE $60.37
  • NSA $49.44
  • Technical
  • Relative Strength Index (RSI)
  • RARE 51.86
  • NSA 34.31
  • Support Level
  • RARE $36.03
  • NSA $32.08
  • Resistance Level
  • RARE $37.74
  • NSA $33.43
  • Average True Range (ATR)
  • RARE 1.46
  • NSA 0.63
  • MACD
  • RARE -0.01
  • NSA -0.05
  • Stochastic Oscillator
  • RARE 26.56
  • NSA 15.12

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

About NSA National Storage Affiliates Trust of Beneficial Interest

National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.

Share on Social Networks: